
    
      Patients with more than 3-month-history of peritoneal dialysis and hyperuricemia. Use
      Febuxostat to control their serum uric acid for 1 year. To observe the cardiovascular events
      of patients, and compare and evaluate the changes of heart function, heart construction,
      serum cardiac markers and brain natriuretic peptide (BNP) levels before and after Febuxostat
      treatment.
    
  